Your trusted destination for CME, CPD & Medical Education across the Middle East.
The Gulf Thoracic Conference 2027 is a three-day scientific meeting focused on the latest advances in thoracic medicine, pulmonology, respiratory diseases, and thoracic surgery. The conference will bring together healthcare professionals to explore evidence-based approaches and emerging developments in areas such as lung cancer, COPD, asthma, interstitial lung disease, pulmonary hypertension, interventional pulmonology, minimally invasive thoracic surgery, and critical care. It provides an opportunity for multidisciplinary learning, clinical knowledge exchange, and professional development.
The Gulf Thoracic Conference 2027 is an upcoming scientific meeting dedicated to advancing knowledge and clinical practice in thoracic medicine, pulmonology, respiratory care, and thoracic surgery. The conference will bring together healthcare professionals and specialists to discuss current developments, emerging technologies, and evidence-based approaches in the diagnosis and management of thoracic and respiratory diseases. The scientific program is designed to address important areas of modern thoracic care, including lung cancer and thoracic oncology, interventional pulmonology, airway diseases, COPD, asthma, interstitial lung disease, pulmonary hypertension, pleural diseases, thoracic surgery, minimally invasive and robotic procedures, lung transplantation, and critical care. The conference provides an opportunity for physicians and allied healthcare professionals to exchange clinical experience, explore advances in diagnosis and treatment, and discuss challenging cases and evolving approaches in thoracic medicine. It is particularly relevant to professionals working across pulmonology, thoracic surgery, oncology, critical care, radiology, and respiratory healthcare.
Exploring current guidelines and advanced imaging techniques for the early identification of thoracic malignancies.
Updates on immunotherapy, targeted therapies, and chemotherapy regimens for lung cancer and other chest tumors.
Reviewing innovations in surgical approaches, including minimally invasive techniques like VATS and robotic surgery.
Discussing novel biologics, advanced inhaler therapies, and personalized treatment strategies for severe obstructive airway diseases.
Covering diagnostic algorithms and management protocols for simple and complex pleural conditions, including empyema.
Highlighting the role of advanced bronchoscopy, EBUS, and other interventions in diagnosing and treating airway and pleural diseases.
Emphasizing a multidisciplinary approach, including HRCT interpretation and pathological correlation, for diagnosing fibrotic and non-fibrotic ILDs.
An overview of antifibrotic agents and new therapeutic targets for idiopathic pulmonary fibrosis (IPF) and other progressive ILDs.
Updates on the diagnosis, classification, and management of pulmonary hypertension, particularly in the context of chronic lung disease.
Comparing techniques, outcomes, and patient selection for video-assisted (VATS) and robotic thoracic surgical procedures.
Discussing referral criteria, surgical considerations, and the management of post-transplant complications.
Reviewing evidence-based ventilation strategies, adjunctive therapies, and long-term outcomes for patients with ARDS.
Secure your seat and earn full credit eligibility with encrypted checkout.
Secure payment processing & PCI-aligned flow